Evogene Ltd. EVGN 深 沪
等待开盘 11-04 09:30:00 美东时间
1.26
0.000
0.00%
华盛通- 最 高1.27
- 今 开1.26
- 成交量 3.37万股
- 最 低 1.25
- 昨 收 1.26
- 总市值 1097.99万
- 52周最高 2.42
- 市盈率 静 --
- 换手率 0.39%
- 52周最低 0.95
- 委 比 -25.74%
- 总股本 871.42万
- 历史最高 203.90
- 量 比 0.67
- 振 幅 1.59%
- 历史最低 0.95
- 每 手 1
- 风险率 0.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多EverGen Infrastructure Reports Strong RNG Production and Strategic Advancements
An announcement from EverGen Infrastructure Corp. ( ($TSE:EVGN) ) is now availa...
09-27 08:08
Earnings Scheduled For August 19, 2025
Companies Reporting Before The Bell • Home Depot (NYSE:HD) is estimated to repo...
08-19 16:32
Evogene Shareholders Approve Proposals at Annual Meeting
Evogene ( ($EVGN) ) has issued an update. On August 18, 2025, Evogene Ltd. anno...
08-19 04:28
Preview: Evogene's Earnings
Evogene (NASDAQ:EVGN) is gearing up to announce its quarterly earnings on Tuesd...
08-18 23:02
EverGen Infrastructure Appoints Maria O’Sullivan as Interim CFO
The latest announcement is out from EverGen Infrastructure Corp. ( ($TSE:EVGN) ...
06-27 14:33
Evogene (EVGN) Stock Doubles on AI and Google News
Evogene ($EVGN) is enjoying today’s trading with the stock shooting up 100%. Ev...
06-11 17:14
Evogene Announces Leadership Change and Strategic Shift at Biomica
Evogene ( ($EVGN) ) has issued an announcement. Evogene Ltd. announced a signif...
06-06 04:48
美股大行评级 | 高盛上调微软目标价从480美元至550美元，Snowflake获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132593314765758464.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持IDEAYA Biosciences(IDYA)"超配"评级，目标价从63美元升至66美元</p> <p>• Needham：上调Inogen(INGN)评级至"买入"，目标价12美元</p> <p>• E
05-23 11:19
Lake Street Maintains Buy on Evogene, Lowers Price Target to $3.5
Lake Street analyst Ben Klieve maintains Evogene (NASDAQ:EVGN) with a Buy and lowers the price target from $5 to $3.5.
05-22 23:53
Evogene Q1 EPS $(0.38) Beats $(0.63) Estimate, Sales $2.44M Miss $4.42M Estimate
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.63) by 39.68 percent. This is a 50 percent increase over losses of $(0.76) per share from the same
05-21 19:01
